BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology

A. Keat, N. Barkham, A. Bhalla, K. Gaffney, H. Marzo-Ortega, S. Paul, F. Rogers, M. Somerville, R. Sturrock, P. Wordsworth, BSR Standards, Guidelines and Audit Working group

Research output: Contribution to journalArticle

77 Citations (Scopus)
Original languageEnglish
Pages (from-to)939-947
Number of pages9
JournalRheumatology
Volume44
Issue number7
DOIs
Publication statusPublished - Jul 2005

Keywords

  • Antibodies, Monoclonal/adverse effects
  • Antirheumatic Agents/adverse effects
  • Cost of Illness
  • Etanercept
  • Humans
  • Immunoglobulin G/adverse effects
  • Immunologic Factors/adverse effects
  • Infliximab
  • Receptors, Tumor Necrosis Factor/therapeutic use
  • Severity of Illness Index
  • Spondylitis, Ankylosing/diagnosis
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha/antagonists & inhibitors

Cite this